AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
7.38
+0.72 (10.81%)
At close: Jun 26, 2026, 4:00 PM EDT
7.39
+0.01 (0.14%)
After-hours: Jun 26, 2026, 7:58 PM EDT
AbCellera Biologics Employees
AbCellera Biologics had 562 employees as of December 31, 2025. The number of employees decreased by 34 or -5.70% compared to the previous year.
Employees
562
Change (1Y)
-34
Growth (1Y)
-5.70%
Revenue / Employee
$140,940
Profits / Employee
-$256,149
Market Cap
2.25B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| ADMA Biologics | 647 |
| Nuvation Bio | 307 |
| Harmony Biosciences Holdings | 293 |
| Kardigan | 241 |
| Precigen | 160 |
| Kodiak Sciences | 130 |
| Nektar Therapeutics | 63 |
ABCL News
- 10 days ago - Jazz Pharma, AbCellera ink antibody deal worth up to $876 million - Reuters
- 10 days ago - Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies - Business Wire
- 22 days ago - AbCellera appoints Victor Sandor to board of directors - TheFly
- 22 days ago - AbCellera Appoints Dr. Victor Sandor to its Board of Directors - Business Wire
- 22 days ago - AbCellera Biologics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - AbCellera Biologics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - AbCellera price target raised to $8 from $7 at Stifel - TheFly
- 6 weeks ago - AbCellera Biologics Earnings Call Transcript: Q1 2026 - Transcripts